ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Analytical Method Validation, Verification and Transfer - 2 Day Virtual Seminar, Oct 7th- 9th, 2025 - ResearchAndMarkets.com

The "Analytical Method Validation, Verification and Transfer Virtual Seminar (Oct 7th - Oct 9th, 2025)" has been added to ResearchAndMarkets.com's offering.

Dependable analytical results are essential to making a knowledgeable choice about the excellence and care of the products in the medicinal business. Additionally, such investigative data is required for supervisory submissions in the provision of the drug creation recordings. Therefore, expressive untried projects including scheme appropriateness limits must be planned for the intended use of the process.

In this Analytical Method Validation Training Course, a general guideline for the determination of the analytical characteristics for different types of validation procedures is highlighted for the analysis of both the drug substance and drug product. The factors to consider for verification of the compendial procedures will also be discussed.

In addition, different approaches for the transfer of analytical procedures from one lab (transferring) to another lab (s) (receiving) under different circumstances will be covered. Other related topics for obtaining reliable data will also be discussed. These topics include analytical instrument qualification as well as how to set, handle and monitor specifications.

In this Analytical Method Validation Training Course, the overall recommendation for the purpose of the logical features for diverse types of authentication measures is highlighted for the examination of the drug substance and drug product. The trainees will be required to pay attention to the influences to reflect for confirmation of the compendial actions that are an indivisible part of the training course. In addition, different methods for the transmission of the analytical procedures from one lab (transferring) to another lab (s) (receiving) under different conditions will be enclosed. Other related topics for obtaining reliable data will also be discussed. These themes comprise logical tool requirements as well as how to set, grip and screen specifications.

Learning Objectives

The Analytical Method Validation Training Course follows a few objectives that every aspiring candidate needs to focus on while undergoing the course:

  • Drug Endorsement Process and Controlling Necessities (secluded values)
  • Substitute Official methods and options
  • Allowed Alterations of Chromatographic System Strictures
  • Pharmacopeias and Compendial Approval Process (public standards)
  • Logical Method Life Cycle
  • Investigative Method Authentication
  • Compendial Coordination Procedure
  • Analytical Instrument Qualifications including DQ, IQ, OQ, PQ
  • Analytical Method Verification
  • Analytical Method Transfer
  • Chromatography System Appropriateness Necessities
  • Analytical Method Validation
  • How to Set Specifications and how to handle out-of-specification (OOS) and out-of-trend (OOT) results

Who Should Attend:

  • Contract Laboratories (CRO), Academia (pharmacy, Pharmaceutical Industry, Pharmaceutical, Chemistry), government (FDA or regulatory authorities)
  • Quality Analysis Managers and Personnel
  • Controlling Personnel
  • Analytical and or Formulation Chemists
  • Quality Control Managers and Personnel
  • Lab Supervisors and Managers
  • Compendial Liaisons
  • Senior or Graduate students (chemistry, pharmaceutical, pharmacy)
  • Pharmaceutical scientists/Pharmacists working in Industry

Course Agenda:

  • Seminar objectives review, expectations, and scope.
  • Pharmacopoeias and Compendial (USP) Approval Process (public standards)
  • Analytical Method Validation (typical validation parameters)
  • Drug Approval Process and Regulatory (FDA) Requirements (private standards)
  • Chromatography System Suitability Requirements
  • Compendial Harmonization Process
  • Qualification Phases (DQ, IQ, OQ, PQ)
  • Precision/Accuracy
  • Allowed Adjustments of Chromatographic System Parameters
  • Specificity
  • Factors to Consider
  • LOD and LOQ
  • Analytical Method Verification
  • Analytical Instrument Qualifications
  • Analytical Method Transfer
  • Linearity/Range
  • FDA and USP Requirements
  • Instrument Categories
  • Different Approaches
  • Summary and Review
  • Investigative Procedure Life Cycle
  • Setting Stipulations FDA rules and ICH strategies (Q6A)
  • Out-of-Specification (OOS)
  • Out of Trend (OOT)
  • How to handle OOS and OOT
  • Summary and Review

For more information about this training visit https://www.researchandmarkets.com/r/s7iobq

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.